Related Experiment Video
Updated: Jan 23, 2026

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro
Published on: January 9, 2018
Natural killer cell exhaustion in ovarian cancer: from molecular suppression to therapeutic revival
1Department of general gynecology II, Gynecology and Obstetrics Center, the First Hospital of Jilin University, Changchun, China.
Abstract:
Ovarian cancer remains one of the most lethal gynecologic malignancies, largely due to its late-stage diagnosis and the establishment of an immunosuppressive tumor microenvironment (TME). Natural killer (NK) cells, key effectors of innate immunity, exhibit impaired cytotoxicity within this hostile niche. The dysfunction arises from multiple mechanisms, including suppression by immunosuppressive cytokines (TGF-β, MUC16), shedding of activating ligands (MICA/B, B7-H6, CD155), overexpression of inhibitory immune checkpoints (PD-1, TIGIT), and metabolic reprogramming shaped by glucose and lipid competition. Recent advances in NK cell-based immunotherapies-such as cytokine modulation, adoptive NK transfer, and checkpoint blockade-have demonstrated potential to reverse NK exhaustion and enhance antitumor efficacy. In this review, we systematically dissect the molecular and cellular pathways underlying NK cell suppression in ovarian cancer and evaluate emerging strategies to reinvigorate NK-mediated immunosurveillance.
Insights
Ovarian cancer is lethal due to late diagnosis and an immunosuppressive tumor microenvironment (TME) that impairs Natural Killer (NK) cells. This review explores strategies to overcome NK cell dysfunction and enhance cancer immunity.
Area of Science:
- Immunology
- Oncology
- Gynecologic Oncology
Background:
- Ovarian cancer is a leading cause of cancer death, often diagnosed late.
- The tumor microenvironment (TME) in ovarian cancer is highly immunosuppressive.
- Natural Killer (NK) cells, crucial for innate immunity, are functionally impaired within the ovarian cancer TME.
Purpose of the Study:
- To dissect the mechanisms of NK cell suppression in ovarian cancer.
- To evaluate emerging immunotherapeutic strategies for ovarian cancer.
- To identify ways to reinvigorate NK cell-mediated antitumor responses.
Main Methods:
- Systematic review of molecular and cellular pathways.
- Analysis of NK cell dysfunction in the ovarian cancer TME.
- Evaluation of current and novel NK cell-based immunotherapies.
Main Results:
- NK cell dysfunction is driven by immunosuppressive cytokines (e.g., TGF-β, MUC16), ligand shedding, inhibitory checkpoint expression (e.g., PD-1, TIGIT), and metabolic alterations.
- Ovarian cancer's TME actively suppresses NK cell cytotoxicity.
- Emerging immunotherapies show promise in restoring NK cell function.
Conclusions:
- Understanding NK cell suppression mechanisms is critical for effective ovarian cancer treatment.
- NK cell-based immunotherapies offer a promising avenue to enhance immunosurveillance and combat ovarian cancer.
- Reinvigorating NK cells could overcome treatment resistance and improve patient outcomes.
Related Concept Videos
Nature and Nurture
What is Natural Selection?
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Therapeutic Index
Molecular Models
Ovarian Cycle

